MedTrace Logo

Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

NCT01937221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-01-31

No results posted yet for this study

Summary

The goal of this study is to create new retinal imaging processing software useful for the development of novel retinal biomarkers of cognitive impairment associated with Alzheimer's disease (AD).

Conditions

Interventions

OTHER

spectral-domain optical coherence tomography (SD-OCT)

Intervention same to all groups.

Sponsors & Collaborators

Principal Investigators

  • Heather Whitson, MD, MHS · Duke University

  • Eleonora Lad, MD, PhD · Duke University

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01937221 on ClinicalTrials.gov